Most important medical research has been, and still is, carried out in the laboratory or in the ward on a small number of patients under the personal care of the investigator. There is, how-
ever, a class of research that requires observations to be made, and sometimes indeed actual experiments to be carried out, on such large numbers that it is impossible for it to be conducted by the doctors who have personal responsibility for the patients' care. In these circumstances, people have to be traced, their causes of death determined, and information about them obtained from personal interview, questionnaire, or industrial or other social records. Very often also, clinical information that has been obtained in confidence in the course of medical consultation has to be passed from the doctor who obtained it to the epidemiologist responsible for the investigation and to his research assistants, either directly or through the medium of some central collecting agency. Consider briefly four examples.
When in 1955 anxiety began to be expressed about the possibility that radioactive fallout from the test explosion of hydrogen bombs might be dangerous to health, the MRC was unable to advise the government because of the lack of evidence on which to base its advice. It was known, of course, that ionizing radiations could produce cancer, but the cancers that had been attributed to radiation had occurred against a background of extensive tissue damage and many believed that they were produced only if the dose exceeded a specified amount which might be as much as several hundred rads. Some preliminary observations on the Japanese who had been exposed to, and survived, the atomic bomb explosions and on patients who had been irradiated for ankylosing spondylitis (Court Brown & Abbatt 1955) suggested that it might be possible to obtain evidence of the nature of the relationship between the dose of radiation and the incidence of cancer by studying the incidence of leukemia in spondylitic patients who had received different amounts of treatment. Court Brown and I were, therefore, asked to carry out such an investigation. With the assistance of 47 colleagues we sought and obtained information about 13 000 patients who had been treated at 81 radiotherapy centres throughout the UK from 1935 to 1954 inclusive. The radiotherapy notes provided information about the doses received, and an individual follow up, which was achieved for some 98 % of the patients, provided evidence about the incidence of leukwemia. The results did not support the belief in a threshold; but on the contrary suggested that the incidence of the disease was approximately proportional to the dose received. Calculations based on the results led to the conclusion that some 15 to 20 cases might be produced among 1 000 000 people for every rad of radiation received averaged over the whole of the active marrow (Court Brown & Doll 1957 , 1959 , and 1965 .
A study of this sort has many weaknesses, but it has the advantage that the results refer directly to the animal whose disease we are trying to prevent. In the absence of detailed knowledge of the mechanisms by which cancer is produced, the International Commission on Radiological Protection used evidence of this type to draw up recommendations for the protection of radiation workers and the general public against the noxious effects ofexcessive irradiation.
My second example concerns the use of combinations of oestrogen and progestogen as oral contraceptives. These preparations were introduced into clinical practice in 1956 and within a few years their use had spread round the world. Few of the possible effects that had worried endocrinologists before they were introduced appear to have occurred: but others have. One was suggested in 1961 when Jordan, a general practitioner in Suffolk, reported that a patient had developed venous thrombosis and pulmonary embolism after taking Enovid for the treatment of endometriosis. Many other similar accounts were published in the next five years, but their significance was difficult to assess because the incidence of thrombosis was obviously low and similar events were known to occur occasionally in young women without any evident cause. In 1966 the position was still unclear and Vessey and I began a retrospective study of patients who were ill enough to have been admitted to hospital. Cooperation was sought and obtained from the medical staff of all the 19 general hospitals with more than 300 beds situated in the catchment area of the North-West Metropolitan Regional Hospital Board, which maintained a sufficiently detailed nosological index.
At each hospital the index was searched and the case notes reviewed for all the women under 41 years of age who had been diagnosed as suffering from venous thromboembolism, and those who met specified criteria were included in the study. For each affected patient, two controls were selected who had been admitted to hospital for a variety of other acute medical or surgical conditions. Permission to interview the patients was obtained from their general practitioners and the relevant hospital consultants and the patients were interviewed in their homes by a medical social worker. Those few patients who could not be interviewed personally were asked to complete a questionnaire. The results showed that women who used oral contraceptives were six or seven times as likely to be admitted to hospital for venous thromboembolism as other comparable women and suggested that the preparations were responsible for the development of the disease (Medical Research Council 1967 , Vessey & Doll 1968 , 1969 . In a subsequent study, Inman and his colleagues analysed the reports of thromboembolism received by drug safety committees in the UK, Sweden and Denmark (Inman et al. 1970 ). The number of reports associated with different preparations was found to differ from the number that would have been expected from estimates of sales, if all preparations had carried the same risk. Relatively more of the reports were attributed to pills that contained the higher doses of oestrogen and the ratio of the number received to the number expected increased progressively with dose from 50 to 150 ,ug, irrespective of whether the aestrogen was mestranol or ethinyl ecstradiol. The dose was therefore reduced, and with it, there is reason to believe, the risk (Royal College of General Practitioners 1974).
A third example is provided by a study of the causes of death of gas workers which was started in 1949 to see whether exposure to fumes from coal tar was likely to cause lung cancer and was continued, at the request of the Ministry of Fuel and Power (as it then was), in the hope of defining more accurately the extent of the risk and the situations in which it was specially liable to occur. The first part of the study was confined to men who had been employed by a large London gas company and were in receipt of a pension on 1 January 1939, or who began to receive a pension in the succeeding ten years. Information about the fate of the men was obtained entirely from the records of the Company, which included a copy of the certified cause of death. The numbers of deaths observed in different categories were compared with the numbers which, it was calculated, would have occurred had the men experienced the mortality rates in London as a whole. The results showed no appreciable difference between the numbers of deaths observed and expected either in total or for any individual cause other than lung cancer; for lung cancer the numbers were 25 observed and 13.8 expected (Doll 1952) . In the second part of the study information was sought about men who were employed by, or were in receipt of a pension from, any one of four area Gas Boards. Nearly 12 000 men were studied who were aged between 40 and 65 years of age, had been employed by the industry for more than five years, and were employed in certain selected occupations. All but 50 (0.4%) were successfully followed for eight years. The results showed that the excess mortality from lung cancer was confined to men with exposure to coal tar in gasproducing plants and suggested that the risk was greater with the use of the old-fashioned horizontal retort than with the more modern vertical retort (Doll et al. 1965 , Doll et al. 1972 . My last example comes from Denmark and concerns the possibility of a relationship between infectious mononucleosis and Hodgkin's disease (Rosdahl et al. 1974) . That the infection might be related to cancer had been suggested on cytological grounds and by the discovery that it was due to a virus that was known to be closely related to Burkitt's lymphoma. Several investigators reported the association of mononucleosis and Hodgkin's disease in individual patients, but the relationship was difficult to pursue because of the difficulty of confirming a history of the infection. A study was possible in Denmark because of the existence of two sets of records. One was of the records of Paul-Bunnell tests that had been carried out centrally in the State Serum Institute in Copenhagen since 1939, the other was the notifications of patients with cancer that had been received by the Danish Cancer Registry since 1943. All that had to be done, therefore, was to compare the names recorded in the Institute and the Registry. Altogether 16 167 patients were found to have had a positive Paul-Bunnell reaction at a titre of 1/32 or higher, for whom adequate identifying data were available. Of these 16 were found to have developed Hodgkin's disease between one and six years after the diagnosis of infectious mononucleosis had been made, whereas 2.0 would have been expected. The results will, of course, need to be confirmed in other series; but if they are, they will provide presumptive evidence of a causal relationship between the virus and the development of cancer which could be of considerable importance, from the point of view of both practice and theory.
The studies that I have described are typical of many epidemiological investigations. They depend for their success on the maintenance of clinical records in hospitals, the existence of nosological indexes, and the willingness of doctors to provide access to their notes and to allow their patients to be followed up and, on occasions, interviewed. Sometimes they require access to industrial or other social records and very often to central registers of death or morbidity.
Until recently the propriety of maintaining such records and the right of epidemiologists to have access to them under defined conditions was taken for granted. Now, however, with the growth in the number of registers and in particular, with the development of computers which enable the registers to be manipulated with ease and celerity, these principles have been challenged. Not that there has been any suggestion that medical information that has been passed from one doctor to another or to a central register has been used to the detriment of the patient. Concern has been felt primarily over the release of information about, for example, an individual's credit rating; but the extension of computers into the medical field has given rise to anxiety about the possibility that medical information might be made available for nonmedical purposes. This concern was voiced by Mrs Shirley Williams (1973) in the House of Commons during the debate on the Report of the Committee on Privacy. 'It needs', she said 'only a moment's imagination to realize if one could link up medical records with employment records in such a way as to reveal, for instance, past treatment for psychiatric illnesses or VD, how widely we are extending the power over individuals in a way that frankly I find extremely disturbing.' Unfortunately such concern, which is both understandable and proper, has led to a mistrust of all interchange of medical information, so that the view has been expressed that information that is not required for the direct benefit of the patient should not be passed to anyone, not even to another doctor, without the explicit consent of the patient.
If this view were accepted it would make the conduct of epidemiological investigation extremely difficult, and would introduce the risk of so biasing an investigation that the results would not be reliable. Fortunately, it does not seem to have appealed to the medical profession. In the last 28 years my colleagues and I must have sought and obtained detailed medical information about 40 000 individuals, without their explicit consent. So far as I can recall it has been refused on two occasions. Once when inadvertently a research assistant had interviewed the private patient of a surgeon at a leading London hospital and once when I was seeking information about the validity of the diagnosis of cancer of the lung from which a doctor, who had given us details of his smoking habits, was said to have died. Both events occurred more than 15 years ago. During this time I have invited hundreds of doctors to collaborate in studies that required access to the clinical records of identified individuals and have been refused only once on the grounds of confidentiality. That was two years ago when Dr Kinlen and I were seeking notification of patients who had been treated with immunosuppressive drugs in order to assess their effect on the subsequent development of malignant disease. On one other occasion I was refused permission to interview patients in a specialist gyneecological hospital which I had sought as part of a study of the causes of cervical cancer; but that was on the grounds, more understandable in the 1950s than it would be now, that a social worker should not ask patients about the frequency of intercourse. On several occasions recently doctors have hesitated to provide the information requested without first obtaining the patient's written consent. I have met this objection by citing the Medical Research Council's evidence to the Committee on Privacy, now codified in a public statement (Medical Research Council 1973) , which states that: ' The Council considers that, subject to certain safeguards, medical information obtained about identified individual patients should continue to be made available without their explicit consent for the purposes of medical research.' These safeguards, all of which are perfectly practicable, include the proviso that information should be communicated 'only if, in the opinion of the medical practitioner holding that information, such communication will not harm the subject's interests' and that 'the results of investigations should never be presented in such a way that identification of individual subjects might be possible'. This statement has been approved by the British Medical Association and reference to it has always achieved the collaboration I sought with the one exception of the doctor who refused to collaborate in the study of immunosuppressive drugs.
Another side-effect of the concern for privacy has been the suggestion that it is improper to observe an individual without his knowledge or consent to see whether he develops a particular disease. At first sight this may appear an attractive proposition, but in practice it is neither necessary nor desirable. Many studies like that of the mortality from lung cancer among gasworkers involve only the organization of information that already exists so that the public as a whole can benefit from it. Legislation to regulate the disclosure of any sort of information about an individual to research workers, or to anyone else, would be welcome but it would be stupid to insist that an individual should be required to give consent to being traced, when tracing him to secure the consent provides all the essential information. And it would be positively harmful to have to worry people with the idea that they might be exposed to an increased risk of developing an unpleasant disease if, as a result of the research, the risk was shown to be non-existent. Dr Armstrong and I are now following up a group of diabetic patients to see whether the use of saccharin has exposed them to an increased risk of developing cancer of the bladder. All we need to know is whether they are still alive, which can usually be discovered from hospital clinic or general practitioner, or, if they have died, the cause of death, which can be discovered from a public document. I cannot see that it would be in the interest of the patients to require me to tell them that I was trying to show that the results of animal experiments were not (as I suspect) relevant to their situation. Nor can I believe that it would help patients who have been treated with a certain drug to tell them that it has been found incidentally in the course of another study to be associated with the development of breast cancer-which is why we are following them up and the reason why I will not mention the name of the drug today (though the finding has, of course, been reported to the Committee on Safety of Medicines). In the course of our work my colleagues and I must have followed up more than 100 000 people, mostly without previous consultation. Only one patient, a woman with ankylosing spondylitisor to be accurate her husbandhas shown any objection to being traced for the purposes of medical research. Many thousands have, on the contrary, written to express their gratitude. In the examples cited, the doctors who were in charge of clinics acted on behalf of the patients and gave their consent to the investigation. I did not in 1950 seek the approval of the trade union representatives for the first study of the mortality of gasworkers, but I did in the second study and it is a wise precaution to do so now before investigating a suspected industrial hazard, which management will, in any case, wish to adopt.
The position is, of course, different if one wishes to obtain the personal collaboration of the patient in, for example, completing a questionnaire. In that case, in the words of the Medical Research Council (1973) 'the right of those approached to refuse it without giving a reason must always be respected'. This, however, seldom proves an obstacle, as the vast majority of people are glad to assist in medical research, even at the cost of some personal inconvenience.
Of the four examples to which I referred at the beginning of this talk, three depended on access to central registers of morbidity or mortality. The most important of these, the register of deaths, is open to the public and anyone who cares to pay the fee can secure a copy of the certificate and examine the cause. For the purposes of epidemiological research, the only problems are to identify the subject and to check the accuracy of the diagnosis. Identification was greatly facilitated when, in 1969, the date of birth of the decedent was substituted for his age and place of birth and married woman's maiden name were added to the certificate; and it will be facilitated further when similar information is included routinely on all medical records.
To check the cause of death, it is often necessary to refer back to the hospital in which the patient had last been treated. This seldom gives rise to problems, as most doctors agree that once a patient has died, the passing of information to another doctor about his medical state before death is unlikely to do him any material harm. This is in sharp contrast to the position in Germany, where a request for information about the medical background to a fatal illness is commonly met by the incontestable objection that it is not possible to obtain the decedent's permission to reveal it.
A more serious difficulty is the growing tendency for hospitals to destroy records that are more than six years old. When the Ministry of Health (as it then was) first issued a directive that hospitals could destroy notes that had been inactive for six years, I was assured that the Ministry had no intention of recommending this procedure. All that it intended to do was to point out that there was no legal requirement to retain notes for a longer period. In fact, however, a maximum storage period of six years is provided for in hospital building notes and it is becoming increasingly difficult for hospital authorities to find space to house them any longer, or, for financial reasons, to substitute a proper micro-filming programme. If a policy of destruction is put into effect, many studies that make use of past experience will be impossible and we shall have to delay conclusions about, say, the carcinogenic effect of drugs, until new experience is accumulated. It is time that the Department advised the Health Authorities that responsible organizations keep their records for 20 years -not 6.
My fourth example of an epidemiological study illustrated the value of specialized registers, in particular a register of morbidity from cancer which, together with accidents and ischamic heart disease, now constitutes the principal threat to public health during the years of productive life. Several registers are now maintained on a national scale, either centrally, as the register of adverse reactions to drugs and the cancer register, or locally, as the registers of births, congenital anomalies, infectious diseases, immunization procedures, and cervical cytology that are maintained by Area or Regional Medical Officers. All these, and many more, have their uses, but they would be of far greater value if linked (or capable of being linked) with causes of hospital admission or death. Linked in such a way it should be possible to provide answers within days or weeks to many of the questions that are now regularly asked when people are exposed to new drugs, new industrial processes and products, and new pollutants. No matter how much care is taken to test the effect of new products before they are introducedand it is no easy matter to arrange for long-term toxicity testing of industrial products before they are shown to be of commercial value -a material may still have an unsuspected effect in man, producing perhaps cancer, fetal abnormality, or some bizarre syndrome such as progressive pulmonary hypertension.
The detection of a risk is not, of course, the end of an epidemiological study. Few activities in life do not carry some risk and none, I suspect, that are enjoyable. If cyclamates and saccharin cause cancer of the bladder in man, they may still be better for diabeticsand even for healthy peoplethan large amounts of sugar. We need, therefore, to be able to put some quantitative limits on the size that the risk may be. To do so in such a way that is economic in cost and time, we need a system that will bring together the main medical events in the life of an individual and make them available to the research worker. Such a system would, of course, also be of value in the care of individual patients and in the management of the health service; but these considerations are not relevant to today's discussion. A record system of the sort that I have described has been made possible by the development of computers and would be easy enough to protect against harmful or unauthorized disclosure by proper organization and legal restriction. But whether we are to have it is for the public, not the medical profession, to choose. It is our responsibility only to ensure that the choice is based on informed opinion. Research workers will, in any case, continue to need access to personal information on a large scale if the public is to be protected against the hazards of living in a complex industrialized society. In my experience, the great majority of people understand this perfectly well and have confidence in the professional research worker whether he is employed by the Medical Research Council, the University, or a private charity. We must be careful not to make the mistake that was made by the town council of Kilmarnock, when it abandoned the fluoridation of water as a result of the pressure of small groups, at a time when the University Department of Social Medicine at Edinburgh was able to show that the majority of the population wanted fluoridation to continue.
